Cardium’s Excellagen topical gel for diabetic feet ulcers receives FDA 510 clearance Cardium Therapeutics announced today that it all has received 510 clearance from the U.S. Directions for use indicate the application of Excellagen rigtht after surgical debridement, which is routinely practiced in the treatment of diabetic foot ulcers and various other dermal wounds. Excellagen is usually a highly-refined fibrillar flowable bovine collagen topical gel which will initially be marketed as a sterile, syringe-based advanced wound treatment product for the management of diabetic feet ulcers following surgical debridement methods.The Alzheimer's Association predicts that by 2050, almost 14 million Americans more than 65 will have Alzheimer's. Caring for them will cost around $1 trillion every year. ‘It's a devastating illness just,’ Willette said. ‘Unlike a whole lot of other neurological illnesses, Alzheimer's disease robs you of yourself.’ A groundbreaking study Researchers have very long suspected that inflammation in the mind network marketing leads to the cell death and brain atrophy found in people with Alzheimer's disease. Yet previous studies didn't place much emphasis on the varying roles of different immune proteins and how they could change the mind over time. Within his latest analysis, Willette analyzed data from the Alzheimer's Disease Neuroimaging Initiative, an attempt to collect and archive brain images and spinal liquid samples for experts.